Radient Pharma (RXPC) Approves 1-to-25 Reverse Split
Tweet Send to a Friend
Radient Pharmaceuticals Corporation (OTCBB: RXPC), reports its Board of Directors has authorized the implementation of a 1:25 reverse split of the Company's outstanding common shares, which will be completed on or before January 15, 2012.
Authority for the reverse split was granted to the Board by the Company's stockholders at a November 4, 2011, special meeting.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Authority for the reverse split was granted to the Board by the Company's stockholders at a November 4, 2011, special meeting.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- TransDigm (TDG) Considers $1-$1.8B Special Dividend; Requests to Amend Credit Facility
- Intercept Pharma (ICPT) Prices 1.73M Common Offering at $33.01/Share
- Petrobras (PBR), SINOPEC (SNP) Enter Joint Development Agreement for Maranhão Refinery
Create E-mail Alert Related Categories
Corporate News, Stock Splits
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
